Adverse events ‐ pelvic pain · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ pelvic pain compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Biopsy‐proven recurrence of endometriosis · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Psychological well‐being and coping (primary outcome) · adults (aged 18 or older) with a diagnosis of stroke
1 finding from 1 review
Secondary outcome: quality of life · adults (aged 18 or older) with a diagnosis of stroke
1 finding from 1 review
Physical functional improvement (secondary outcome) · adults (aged 18 or older) with a diagnosis of stroke
1 finding from 1 review
Communication and cognitive functional improvement (secondary outcome) · adults (aged 18 or older) with a diagnosis of stroke
1 finding from 1 review
Physical activity · adults (aged 18 or older) with a diagnosis of stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: all adverse events · adults (aged 18 or older) with a diagnosis of stroke
1 finding from 1 review
Time taken from start of treatment until the resolution of DIOS · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure rate · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adherence · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of acute DIOS · adults and children with cystic fibrosis
1 finding from 1 review
Adverse effects: abdominal mass · adults and children with cystic fibrosis
1 finding from 1 review
Abdominal pain · adults and children with cystic fibrosis
1 finding from 1 review
Change in cough‐related quality of life · people in the post‐acute period following acute exacerbation of bronchiectasis
1 finding from 1 review
Change from baseline in 6MWT (metres) · people in the post‐acute period following acute exacerbation of bronchiectasis
1 finding from 1 review